Reuters Business Channel | Reuters.com

"Shares of Merck & Co. fell on Monday as investors assessed the liability the company must overcome after a $253 million jury award, the first of possibly thousands of lawsuits it faces over pain killer Vioxx.

"Merck was off 54 cents, or 1.92 percent, at $27.52 in afternoon trading on the New York Stock Exchange." [Reuters]